Researchers is substantially boosted its development of an new therapy for amyloid heart disease, employing the compound. Early clinical results indicates significant benefits for those diagnosed with a debilitating condition. The focus highlights BridgeBio's dedication to addressing significant patient requirements in this cardiology arena. … Read More